3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Lymphoma, Non-Hodgkin
21
Leukemia, Lymphocytic, Chronic, B-Cell
14
Lymphoma
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, Follicular
9
Leukemia, Myeloid, Acute
9
Hodgkin Disease
7
Lymphoma, Mantle-Cell
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia
6
Myelodysplastic Syndromes
5
Multiple Myeloma
5
Lymphoma, B-Cell, Marginal Zone
5
Lymphoma, B-Cell
5
Hematologic Neoplasms
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Burkitt Lymphoma
4
Stomach Neoplasms
3
Recurrence
3
Lymphoma, Large-Cell, Immunoblastic
3
Colorectal Neoplasms
3
Waldenstrom Macroglobulinemia
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Leukemia, Myelomonocytic, Juvenile
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Thrombocythemia, Essential
1
Interventions
pembrolizumab
3
Sirolimus
2
Drug Therapy
2
Carboplatin
2
Blood Specimen Collection
2
spartalizumab
1
ixabepilone
1
fludarabine
1
etoposide phosphate
1
durvalumab
1
atezolizumab
1
advexin
1
Topotecan
1
Tissue Banks
1
Thiotepa
1
Radiotherapy
1
Quality of Life
1
Psychology, Positive
1
Psychiatric Rehabilitation
1
Patient Reported Outcome Measures
1
Observation
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Microarray Analysis
1
Methods
1
Leucovorin
1
Ipilimumab
1
Interleukin-2
1
Immunotherapy
1
Immunohistochemistry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Interleukin-2
×
Lymphoid
×
Clear all
NCT07410494
2026-02-18
SELECT-CAR-NK
Essen Biotech
Phase 1/2
Recruiting
85 enrolled